NTA-2

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNTA-2
Drug Alias Namethrombin inhibitors (Nuevolution)NTA-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor IIa inhibitors
TargetsProthrombin
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNuevolution AS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNuevolution AS
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A